Rentschler Biopharma SE Appoints Diana Wiedmann as Senior Vice President Human Relations

* Diana Wiedmann, as Senior Vice President Human Relations, assumes global strategic responsibility for human resources
* Together with Sabine Lotz and Silke Stang, a highly qualified team of three is taking the lead at Rentschler Biopharma’s HR department
* Rentschler Biopharma recognized again by the F.A.Z. as “Germany's most attractive employer” in the biopharma sector

 

Laupheim, Germany and Milford, MA, USA, 01 December 2020 – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Diana Wiedmann (36) has joined Rentschler Biopharma to lead the global HR team in Laupheim and Milford as Senior Vice President, effective November 1, 2020. Diana Wiedmann brings more than 20 years of experience in the financial, electrical and pharmaceutical industry. Previously, she served as Head of Human Resources, overseeing a global team and developing HR management strategies for international companies, including Siemens and the US-based biotech company, Vertex Pharmaceuticals.

“We are very pleased to have gained an experienced leader like Diana to complete our highly qualified HR team, “stated Dr. Frank Mathias, CEO of Rentschler Biopharma. “Our team is the key to our continued success. We, therefore, attach great importance to the long-term development of our teams and our attractiveness as an employer to enable efficient and motivated work. Bringing a wealth of experience, Diana will strategically develop the Human Relations department and strengthen our employer branding. Her extensive expertise in leading global teams and her strategic understanding make her an excellent addition to Rentschler Biopharma as we shape and realize our Strategy 2025 with regards to our employees and corporate culture. “

Diana Wiedmann said: “It is an excellent opportunity for me to take over responsibility for the global management of the Human Relations department in a future-oriented, family-owned company. These turbulent times are particularly suitable for making a difference, as they are driven by digitalization and cultural change, in which growing trust and increasing responsibility spur employees. We will use the innovative and pioneering spirit in the company, both to strengthen this important industry and to contribute to shaping the medicines of tomorrow. Rentschler Biopharma is the perfect fit to implement such visions on a long-term and sustainable basis and to accompany people in times of increasing complexity and demands."

During the course of the year, the HR team was further strengthened by Sabine Lotz, Vice President Human Relations, and Silke Stang, Head of Academy. Sabine Lotz has been with Rentschler Biopharma since April 2019 and, in March 2020, took on responsibility for the entire spectrum of operational HR work for the Laupheim location as Vice President HR. Her focus is on recruiting, the optimization and digitization of existing processes and structures as well as the continuous transformation of the HR team towards a strategic partner for all areas of the company. 

The Rentschler Academy plays an integral part in preparing employees worldwide for the steady growth of Rentschler Biopharma, providing them with the best possible qualifications. Since March 2020, Silke Stang, an experienced manager in the area of employee qualification and training, has led the Academy. She will establish an international and future-oriented training academy, thereby promoting skill development and lifelong learning at all Rentschler locations.
 
Dr. Frank Mathias added: “Rentschler Biopharma is part of an extremely dynamic industry. Following our motto ‘many hands, many minds, one team!’, together, we produce innovative and highly effective drugs. Well-trained employees are the key to this. It is therefore our goal to strengthen each member of the Rentschler Biopharma team – individually and for the long term.“
 
In October 2020, for the third time in a row, the Company was named one of “Germany's most attractive employers” by the F.A.Z. Institute. After two years in second place, Rentschler Biopharma made it to the top in the biopharma category this year.
 
About Rentschler Biopharma SE
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO), focused exclusively on client projects. From its headquarters in Laupheim, Germany and its site in Milford, MA, USA, Rentschler Biopharma offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. In order to offer best-in-class formulation development along the biopharmaceutical value chain, the company has entered into a strategic alliance with Leukocare AG. Rentschler Biopharma is a family-owned company with about 1,000 employees. For further information, please visit www.rentschler-biopharma.com. Follow Rentschler Biopharma on LinkedIn and Facebook.
 
Contact:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
Phone: +49 7392 701-874
communications@rentschler-biopharma.com